Jim Miller - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Jim Miller


Jim Miller Pharmtech contributing editor and EAB member

Jim Miller
President, PharmSource Information Services,
Bio/Pharmaceutical Outsourcing Report

PharmTech Contributing editor, Outsourcing Outlook

Jim Miller is the founder and president of PharmSource. A preeminent expert in bio/pharmaceutical outsourcing, Jim established and presides over the pharmaceutical industry’s principal source of market intelligence on the business of contract research, development and manufacturing of bio/pharmaceuticals. PharmSource’s subscription databases, reports and consulting services are used by major pharmaceutical companies, contract manufacturers and contract research organizations to understand key market trends, identify new business opportunities and establish effective business and sourcing strategies. Jim writes regular columns on outsourcing for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm magazines.

Jim’s other career highlights include a stint as president and chief operating officer of St. Anthony Publishing, a pioneering provider of value-added information services to hospitals and physician practices. He was a consultant in corporate strategy with the Boston Consulting Group, a project economist for the World Bank, and a Peace Corps volunteer in Botswana. He holds an MBA degree from the Stanford University Graduate School of Business.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here